"...Precipio, Inc...announces the launch of its new Quantitative BCR-ABL 2.0 panel, with features making it the most innovative panel of its kind on the market...Precipio’s BCR-ABL assay can detect gene mutations as infrequent as 1 in 100,000. This is twice as sensitive as the next most sensitive qPCR assay on the market."